Detection of acute lymphocytic leukemia (ALL) with a pre-trained deep learning model
International Conference on Recent Academic Studies · 2023
DOI: 10.59287/icras.681 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Conference on Recent Academic Studies, 2023. Verfasst von Şengül DOĞAN und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Acute Lymphocytic Leukemia (ALL) is a type of cancer caused by immature lymphocytes inthe bone marrow. Acute Leukemia is common in both children and adults. It can also cause death if leftuntreated. Hematologists diagnose ALL by examining the blood and bone marrow. This method used isslow and takes more time. In this study, the diagnosis and classification of the disease was carried out usingperipheral smear images with the proposed method. In the proposed method, 99.80% accuracy was obtainedby using the DarkNet19 pre-trained model. Then, 1000 features were obtained from Darknet19. 521 of theobtained features were selected with Mrmr feature selection algorithm. The selected features are classifiedwith support vector machines. An accuracy of 99.94% was achieved with the proposed method. The resultsshow that the proposed method can be used as a tool that will certainly assist pathologists in diagnosingALL and its subtypes.
Zitieren
APA
DOĞAN, Ş., TAŞCI, B., & TUNCER, T. (2023). Detection of acute lymphocytic leukemia (ALL) with a pre-trained deep learning model. International Conference on Recent Academic Studies. https://doi.org/10.59287/icras.681
Vancouver
DOĞAN Ş, TAŞCI B, TUNCER T. Detection of acute lymphocytic leukemia (ALL) with a pre-trained deep learning model. International Conference on Recent Academic Studies. 2023. doi:10.59287/icras.681
BibTeX
@article{DOAN2023,
author = {DOĞAN, Şengül and TAŞCI, Burak and TUNCER, Türker},
title = {Detection of acute lymphocytic leukemia (ALL) with a pre-trained deep learning model},
journal = {International Conference on Recent Academic Studies},
year = {2023},
doi = {10.59287/icras.681}
}
EUVIMED